Correlation Between Abeona Therapeutics and Affimed NV
Can any of the company-specific risk be diversified away by investing in both Abeona Therapeutics and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abeona Therapeutics and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abeona Therapeutics and Affimed NV, you can compare the effects of market volatilities on Abeona Therapeutics and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abeona Therapeutics with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abeona Therapeutics and Affimed NV.
Diversification Opportunities for Abeona Therapeutics and Affimed NV
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Abeona and Affimed is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Abeona Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abeona Therapeutics are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Abeona Therapeutics i.e., Abeona Therapeutics and Affimed NV go up and down completely randomly.
Pair Corralation between Abeona Therapeutics and Affimed NV
Given the investment horizon of 90 days Abeona Therapeutics is expected to generate 0.64 times more return on investment than Affimed NV. However, Abeona Therapeutics is 1.55 times less risky than Affimed NV. It trades about 0.09 of its potential returns per unit of risk. Affimed NV is currently generating about -0.1 per unit of risk. If you would invest 557.00 in Abeona Therapeutics on September 4, 2024 and sell it today you would earn a total of 77.00 from holding Abeona Therapeutics or generate 13.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Abeona Therapeutics vs. Affimed NV
Performance |
Timeline |
Abeona Therapeutics |
Affimed NV |
Abeona Therapeutics and Affimed NV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abeona Therapeutics and Affimed NV
The main advantage of trading using opposite Abeona Therapeutics and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abeona Therapeutics position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.Abeona Therapeutics vs. Reviva Pharmaceuticals Holdings | Abeona Therapeutics vs. Athira Pharma | Abeona Therapeutics vs. Fortress Biotech | Abeona Therapeutics vs. ACADIA Pharmaceuticals |
Affimed NV vs. Pieris Pharmaceuticals | Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |